Multiresistant Gram-negative bacterial infections: Enterobacteria, Pseudomonas aeruginosa, Acinetobacter baumannii and other non-fermenting Gram-negative bacilli;Infecciones causadas por bacterias gramnegativas multirresistentes: enterobacterias, Pseudomonas aeruginosa, Acinetobacter baumannii y otros bacilos gramnegativos no fermentadores

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 31, Issue 6, 2013, Pages 402-409

  Fariñas, María Carmen ^a,b   Martínez Martínez, Luis ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Enterobacteria; Multiresistance; Non fermenting gram negative bacteria

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE AMPC; CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHROMOSOME MUTATION; DISEASE SEVERITY; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; NONHUMAN; PATHOGENESIS; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE INFECTIONS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84879409364     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2013.03.016     Document Type: Article

References (67)

1. L. Martínez-Martínez, and J. Calvo The growing problem of antibiotic resistance in clinically relevant Gram-negative bacteria: Current situation Enferm Infecc Microbiol Clin 28 Suppl 2 2010 25 31
2. N. Woodford, J.F. Turton, and D.M. Livermore Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance FEMS Microbiol Rev 35 2011 736 755
3. J. Ho, P.A. Tambyah, and D.L. Paterson Multiresistant Gram-negative infections: A global perspective Curr Opin Infect Dis 23 2010 546 553
4. A.R. Coates, G. Halls, and Y. Hu Novel classes of antibiotics or more of the same Br J Pharmacol 163 2011 184 194
5. G.H. Talbot The antibiotic development pipeline for multidrug-resistant gram-negative bacilli: Current and future landscapes Infect Control Hosp Epidemiol 31 Suppl 1 2010 S55 S58
6. A.P. Magiorakos, A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, and C.G. Giske Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 2012 268 281
7. F. Navarro, E. Miró, and B. Mirelis Interpretive reading of enterobacteria antibiograms Enferm Infecc Microbiol Clin 28 2010 638 645
8. L. Martínez-Martínez ESBL and permeability barrier Clin Microbiol Infect 13 Suppl 5 2008 82 89
9. L. Martínez-Martínez, A. Pascual, and G.A. Jacoby Quinolone resistance from a transferable plasmid Lancet 351 1998 797 799
10. K.S. Thomson Extended-spectrum-beta-lactamase, AmpC, and carbapenemase issues J Clin Microbiol 48 2010 1019 1025
11. D.L. Paterson, and R.A. Bonomo Extended-spectrum beta-lactamases: A clinical update Clin Microbiol Rev 18 2005 657 686
12. J. Rodríguez-Baño, and A. Pascual Clinical significance of extended spectrum beta-lactamases Expert Rev Anti Infect Ther 6 2008 671 683
13. B. Mirellis, F. Navarro, E. Miro, R.J. Mesa, P. Coll, and G. Prats Community transmission of extended-spectrum B-lactamase Emerg Infect Dis 9 2003 1024 1025
14. J.P. Horcajada, and M.C. Fariñas Involvement of bacterial resistances in community-acquired urinary infections Enferm Infecc Microbiol Clin 23 2005 1 3
15. R. Cantón, A. Oliver, T.M. Coque, M.C. Varela, J.C. Pérez-Díaz, and F. Baquero Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period J Clin Microbiol 40 2002 1237 1243
16. J.R. Hernández, A. Pascual, R. Cantón, L. Martínez-Martínez Grupo de Estudio de Infección Hospitalaria (GEIH) Escherichia coli y Klebsiella pneumoniae productores de beta-lactamasas de espectro extendido en hospitales españoles (Proyecto GEIH-BLEE 2000) Enferm Infecc Microbiol Clin 21 2003 77 82
17. J.R. Hernández, L. Martínez-Martínez, R. Cantón, T.M. Coque, A. Pascual Spanish Group for Nosocomial Infections Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain: A nationwide study Antimicrob Agents Chemother 49 2005 2122 2125
18. A. Valverde, T.M. Coque, M.P. Sánchez-Moreno, V. Pintado, F. Baquero, and R. Cantón Dramatic increase in prevalence of fecal carriage of extended-spectrum betalactamase-producing Enterobacteriaceae during non-outbreak situations in Spain J Clin Microbiol 42 2004 4769 4775
19. J. Rodríguez-Baño, J.C. Alcalá, J.M. Cisneros, F. Grill, A. Oliver, and J.P. Horcajada Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli Arch Intern Med 168 2008 1897 1902
20. M.A. Díaz, J.R. Hernández-Bello, J. Rodríguez- Baño, L. Martínez-Martínez, J. Calvo, and J. Blanco Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: Second nationwide study J Clin Microbiol 48 2010 2840 2845
21. C. Ruiz de Alegría, J. Rodríguez-Baño, M.E. Cano, J.R. Hernández-Bello, J. Calvo, and E. Román Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: Microbiological and clinical features J Clin Microbiol 49 2011 1134 1136
22. J. Blanco, A. Mora, R. Mamani, C. López, M. Blanco, and G. Dahbi National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain J Antimicrob Chemother 66 2011 2011 2021
23. A. Coelho, A. Mora, R. Mamani, C. López, J.J. González- López, and M.N. Larrosa Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain) J Antimicrob Chemother 66 2011 517 526
24. L. López-Cerero, M.D. Bellido, L. Serrano, J. Liró, J.M. Cisneros, and J. Rodríguez-Baño Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance Enferm Infecc Microbiol Clin. 31 2013 385 388
25. J. Rodríguez-Baño, M.D. Navarro, L. Romero, L. Martínez-Martínez, M.A. Muniain, and E.J. Perea Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase- producing Escherichia coli in nonhospitalized patients J Clin Microbiol 42 2004 1089 1094
26. J. Rodríguez-Baño, E. Picón, P. Gijón, J.R. Hernández, J.M. Cisneros, and C. Peña Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli J Clin Microbiol 48 2010 1726 1731
27. R. Ben-Ami, J. Rodríguez-Baño, H. Arslan, J.D. Pitout, C. Quentin, and E.S. Calbo A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients Clin Infect Dis 49 2009 682 690
28. G. Peralta, M. Lamelo, P. Alvarez-García, M. Velasco, A. Delgado, and J.P. Horcajada Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study BMC Infect Dis 12 2012 245
29. G.A. Jacoby AmpC beta-lactamases Clin Microbiol Rev 22 2009 161 182
30. E. Miró, J. Agüero, M.N. Larrosa, A. Fernández, M.C. Conejo, and G. Bou Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain Eur J Clin Microbiol Infect Dis 32 2013 253 259
31. J. Rodríguez-Baño, E. Miró, M. Villar, A. Coelho, M. Gozalo, and N. Borrell Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases J Infect 64 2012 176 183
32. R. Cantón, M. Akóva, Y. Carmeli, C.G. Giske, Y. Glupczynski, and M. Gniadkowski Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe Clin Microbiol Infect 18 2012 413 431
33. V. Miriagou, G. Cornaglia, M. Edelstein, I. Galani, C.G. Giske, and M. Gniadkowski Acquired carbapenemases in Gram-negative bacterial pathogens: Detection and surveillance issues Clin Microbiol Infect 16 2010 112 122
34. J.R. Paño-Pardo, G. Ruiz-Carrascoso, C. Navarro-San Francisco, R. Gómez-Gil, M. Mora-Rillo, and M.P. Romero-Gómez Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak J Antimicrob Chemother 68 2013 89 96
35. C. Pitart, M. Solé, I. Roca, A. Fàbrega, J. Vila, and F. Marco First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain Antimicrob Agents Chemother 55 2011 4398 4401
36. J. Rodríguez-Baño, E. Picón, M.D. Navarro, L. López-Cerero, A. Pascual ESBL-REIPI Group Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli Clin Microbiol Infect 18 2012 894 900
37. A. Endimiani, F. Luzzaro, M. Perilli, G. Lombardi, A. Coli, and A. Tamborini Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase treatment outcome of patients receiving imipenem or ciprofloxacin Clin Infect Dis 38 2004 243 251
38. J. Rodríguez-Baño, M.D. Navarro, P. Retamar, E. Picón, and A. Pascual β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase- producing Escherichia coli: a post hoc analysis of prospective cohorts Clin Infect Dis 54 2012 167 174
39. C.I. Kang, S.H. Kim, W.B. Park, K.D. Lee, H.B. Kim, and E.C. Kim Bloodstream infections due to extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy Antimicrob Agents Chemother 48 2004 4574 4581
40. K.G. Kerr, and A.M. Snelling Pseudomonas aeruginosa: a formidable and ever-present adversary J Hosp Infect 73 2009 338 344
41. R. Sordé, A. Pahissa, and J. Rello Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis Infec Drug Resist 4 2011 31 41
42. J. Vila, and F. Marco Interpretive reading of the non-fermenting gram-negative bacilli antibiogram Enferm Infecc Microbiol Clin 28 2010 726 736
43. P.D. Lister, D.J. Wolter, and N.D. Hanson Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms Clin Microbiol Rev 22 2009 582 610
44. H. Li, Y.F. Luo, B.J. Williams, T.S. Blackwell, and C.M. Xie Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies Int J Med Microbiol 302 2012 63 68
45. G. Cabot, A.A. Ocampo-Sosa, F. Tubau, M.D. Macia, C. Rodríguez, and B. Moya Overexpression of AmpC and efflux pumps in P. aeruginosa from blood stream infections: Prevalence and linkage to resistance in a Spanish multicenter study Antimibrob Agents Chemother 55 2011 1906 1911
46. O. Gutiérrez, C. Juan, E. Cercenado, F. Navarro, E. Bouza, and P. Coll Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals Antimicrob Agents Chemother 51 2007 4329 4335
47. A. Ocampo-Sosa, G. Cabot, C. Rodríguez, E. Román, F. Tubau, and M. Macia Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study Antimicrob Agents Chemother 56 2012 1703 1713
48. M.C. Rodríguez, B. Ruiz del Castillo, C. Rodríguez-Mirones, M. Romo, I. Monteagudo, and L. Martínez-Martínez. Molecular characterization of Pseudomonas aeruginosa isolates in Cantabria, Spain, producing VIM-2 metallo-beta-lactamase Enferm Infecc Microbiol Clin 28 2010 99 103
49. G. Cabot, A. Ocampo-Sosa, M. Domínguez, J. Gago, C. Juan, and F. Tubau Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones Antimicrob Agents Chemother 56 2012 6349 6357
50. R.C. Cezario, D.L. de Mororais, J.C. Ferreira, R.M.C. Pinto, A.L.C. Darini, and P.P. Gontijo Filho Nosocomial outbreak by imipenem-resistant Pseudomonas aeruginosa producing metallo-b-lactamase in adults intensive care unit in a Brazilian teaching hospital Enferm Infecc Microbiol Clin 27 2009 269 274
51. C. Peña, C. Suarez, M. Gozalo, J. Murillas, B. Almirante, and V. Pomar Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections Antimicrob Agents Chemother 56 2012 1265 1272
52. J. Li, R.L. Nation, J.D. Turnidge, R.W. Milne, K. Coulthard, and C.R. Rayner Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections Lancet Infect Dis 6 2006 589 601
53. B.A. Newton The properties and mode of action of the polymyxins Bacteriol Rev 20 1956 14 27
54. M.E. Falagas, S.K. Kasiakou, S. Tsiodras, and A. Michalopoulos The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: A review of the recent literature Clin Med Res 4 2006 138 146
55. E. Chamot, E. Boffi el Amari, P. Rohner, and C. van Delden Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia Antimicrob Agents Chemother 47 2003 264 275
56. C. Peña, C. Suarez, A. Ocampo-Sosa, J. Murillas, B. Almirante, and V. Pomar Effect of adequate single-drug versus combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections. A post hoc analysis of a prospective cohort Clin Infect Dis 2013 doi: 10.1093/cid/cit223
57. I. Roca, P. Espinal, X. Vila-Farrés, and J. Vila The Acinetobacter baumannii oxymoron: Commensal hospital dweller turned pan-drug-resistant menace Front Microbiol 3 2012 148
58. P. Espinal, H. Seifert, L. Dijkshoorn, J. Vila, and I. Roca Rapid and accurate identification of genomic species from the Acinetobacter baumannii group by MALDI-TOF MS Clin Microbiol Infect 18 2012 1097 1103
59. F. Fernández-Cuenca, A. Pascual, A. Ribera, J. Vila, G. Bou, and J.M. Cisneros Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000) Enferm Infecc Microbiol Clin 22 2004 267 271
60. F. Fernández-Cuenca, M. Tomás-Carmona, F. Caballero-Moyano, G. Bou, L. Martínez- Martínez, and J. Vila Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010) Enferm Infecc Microbiol Clin 31 2013 4 9
61. J. Rodríguez-Baño, J.M. Cisneros, F. Fernández- Cuenca, A. Ribera, J. Vila, and A. Pascual Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals (GEIH.Ab 2000 project) Infect Control Hosp Epidemiol 25 2004 819 824
62. J.M. Cisneros, J. Rodríguez-Baño, F. Fernández- Cuenca, A. Ribera, J. Vila, and A. Pascual Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain. A nationwide study Clin Microbiol Infect 11 2005 874 879
63. J. Vila, and J. Pachón Therapeutic options for Acinetobacter baumannii infections: An update Expert Opin Pharmacother 13 2012 2319 2336
64. B. López-Alvarez, R. Martín-Láez, M.C. Fariñas, B. Paternina-Vidal, J.D. García-Palomo, and A. Vázquez-Barquero Multidrug-resistant Acinetobacter baumannii ventriculitis: Successful treatment with intraventricular colistin Acta Neurochir (Wien) 151 2009 1465 1472
65. I.J. Abbott, M.A. Slavin, J.D. Turnidge, K.A. Thursky, and L.J. Worth Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment Expert Rev Anti Infect Ther 9 2011 471 488
66. M.E. Falagas, A.C. Kastoris, E.K. Vouloumanou, P.I. Rafailidis, A.M. Kapaskelis, and G. Dimopoulos Attributable mortality of Stenotrophomonas maltophilia infections: A systematic review of the literature Future Microbiol 4 2009 1103 1109
67. M.E. Falagas, P.E. Valkimadi, Y.T. Huang, D.K. Matthaiou, and P.R. Hsueh Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: A systematic review J Antimicrob Chemother 62 2008 889 894